| 2.81 Data as of 1:03pm ET |  +0.04 / +1.44%Today’s Change | 1.25 Today|||52-Week Range 3.70 | -9.35% Year-to-Date |
| SECTOR Commercial Services | INDUSTRY Miscellaneous Commercial Services | MARKET CAP -- |
Company Description
TherapeuticsMD, Inc. is a specialty pharmaceutical company, which focuses on creating safe and effective therapies exclusively for women. The company's pharmaceutical products are designed to improve the health and well-being of women from pregnancy through menopause. It focuses on the clinical trials for and commercialization of three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal dryness. These proposed hormone replacement products, which contain estrogen and progestin alone or in combination, are being tested to provide equivalent efficacy at lower doses, enabling an enhanced side effect profile compared with competing products. The company was founded in 1907 and is headquartered in Boca Raton, FL.
Employees
Shareholders
| Individual stakeholders | 34.90% |
| Mutual fund holders | 13.72% |
| Other institutional | -- |
Top Executives
| Robert G. Finizio | Chief Executive Officer & Director |
| John C. K. Milligan | President, Secretary & Director |
| Daniel A. Cartwright, CPA | Chief Financial Officer, Treasurer & VP |
| Brian Bernick, MD | Director & Chief Medical Officer |
| Mitchell L. Krassan, MBA, CPA | Chief Strategy Performance Officer & Executive VP |
.
